Castle Biosciences Incorporated

CASTLE BIOSCIENCES

Providing medical diagnostic testing services to dermatologists, surgeons, and oncologists for diagnostic and prognostic purposes for dermatologic cancers, namely, genetic expression profiling and gene sequencing; Providing medical information to dermatologists, surgeons, and oncologists regarding the risk of metastasis for diagnostic support purposes thereby effecting changes in patient treatment plans;BIOSCIENCES;

CONFIRMDX

CONFIRM DIAGNOSIS;CONFIRM MEDICS;CONFIRM DX;Providing medical diagnostic testing services to dermatologists, surgeons, and oncologists for diagnostic and prognostic purposes, namely genetic expression profiling and gene sequencing relating to dermatological cancers, and providing medical information; and providing information for risk of metastasis and diagnostic support thereby effecting changes in treatment plans;

CONFIRMDX-CM

CONFIRM DIAGNOSIS CUTANEOUS MELANOMA;CONFIRM MEDICS CM;CONFIRM DX-CM;Providing medical diagnostic testing services to dermatologists, surgeons, and oncologists for diagnostic and prognostic purposes for dermatologic cutaneous melanoma, namely genetic expression profiling and gene sequencing relating to dermatological cutaneous melanoma, and providing medical information; and providing information for risk of metastasis and diagnostic support thereby effecting changes in treatment plans;

CONFIRMDX-MELANOMA

CONFIRM DIAGNOSIS DX MELANOMA;CONFIRM MEDICS DX MELANOMA;CONFIRM DX-MELANOMA;Providing medical diagnostic testing services to dermatologists, surgeons, and oncologists for diagnostic and prognostic purposes for dermatologic melanoma, namely genetic expression profiling and gene sequencing relating to dermatological melanoma, and providing medical information; and providing information for risk of metastasis and diagnostic support thereby effecting changes in treatment plans;

DECISIONDX

DECISION DX;Providing medical diagnostic testing services for diagnostic and prognostic purposes; and providing medical information;

DECISIONDX-CM

Providing medical diagnostic testing services for diagnostic and prognostic purposes; and providing medical information;

DECISIONDX-CMSEQ

DECISION DX CMSEQ;DECISIONDX CMSEQ;Providing medical diagnostic testing services for diagnostic and prognostic purposes; and providing medical information;

DECISIONDX-CSCC

DECISION DX CSCC;DECISIONDX CSCC;Providing medical diagnostic testing services for diagnostic and prognostic purposes; and providing medical information;

DECISIONDX-MELANOMA

Providing medical diagnostic testing services for diagnostic and prognostic purposes; and providing medical information;

DECISIONDX-PRAME

DECISION DX PRAME;DECISIONDX PRAME;Providing medical diagnostic testing services for diagnostic and prognostic purposes; and providing medical information;

DECISIONDX-SCC

DECISION DX SCC;DECISIONDX SCC;Providing medical diagnostic testing services for diagnostic and prognostic purposes; and providing medical information;

DECISIONDX-UM

Providing medical diagnostic testing services for diagnostic and prognostic purposes; and providing medical information;

DECISIONDX-UMSEQ

DECISIONDX UMSEQ;Providing medical diagnostic testing services for diagnostic and prognostic purposes; and providing medical information;

DIFFDX

Providing medical diagnostic testing services to dermatologists, surgeons, and oncologists for diagnostic and prognostic purposes for dermatologic melanoma, namely genetic expression profiling and gene sequencing using a neural network, artificial intelligence-designed algorithm relating to dermatological melanoma, and providing medical information based on the expression;

DIFFDX-MELANOMA

Providing medical diagnostic testing services to dermatologists, surgeons, and oncologists for diagnostic and prognostic purposes for dermatologic melanoma, namely genetic expression profiling and gene sequencing using a neural network, artificial intelligence-designed algorithm relating to dermatological melanoma, and providing medical information based on the expression;

I-GEP

I GENE EXPRESSION PROFILE; I GENE EXPRESSION PROFILING;Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of integrating the pathology of a tumor, mycotic activity and thickness with a gene expression test using artificial intelligence;

I31-ROR

I THIRTY ONE RISK OF RECURRENCE; I THREE ONE RISK OF RECURRENCE;Medical testing for diagnostic or treatment purposes in the field of integrating the pathology of a tumor, mycotic activity and thickness with a gene expression test using artificial intelligence; Medical testing for diagnostic or treatment purposes;

I31-SLNB

I THIRTY ONE SENTINEL LYMPH NODE BIOPSY; I THREE ONE SENTINEL LYMPH NODE BIOPSY;Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of integrating the pathology of a tumor, mycotic activity and thickness with a gene expression test using artificial intelligence;

RISK IDENTIFIED

Downloadable software in the nature of a mobile application for risk prediction to illustrate the likelihood of sentinel lymph node positivity for a specific patient with cancer invasive melanoma and or sentinel lymph node positivity with invasive melanoma using an artificial intelligence-based, neural network;